Healthcare Time-Driven Activity-Based Costing Should Be Viewed as a Gold Standard

Published Jun 17, 2020

Time-Driven Activity-Based Costing Supports Improved Transparency in Real-World Settings

Value in HealthLawrenceville, NJ, USA—June 17, 2020—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of results of a study suggesting that time-driven activity-based costing can be an effective technique to support value-based healthcare initiatives. The report, “Advances in Value-Based Healthcare by the Application of Time-Driven Activity-Based Costing for Inpatient Management: A Systematic Review,” was published in the June 2020 issue of Value in Health.

This study was developed in collaboration with the Brazilian Health Institute for Technology Assessment, coordinated by Carisi A. Polanczyk, MD, ScD, who is actively working with Ana Paula B.S. Etges, Eng, PhD, in developing several healthcare costs analyses using time-driven activity-based costing. The study reviewed the use of the time-driven activity-based costing methodology and estimated its impact on the value-based healthcare concept for inpatient management. Results indicate that time-driven activity-based costing could be a strategy for increasing cost accuracy in real-world settings, and the method could help in the transition from fee-for-service to value-based systems. The results could further provide a clearer idea of the costs, help with resource allocation and waste reduction, and might support clinicians and managers in increasing value in a more accurate and transparent way.

“In a healthcare system continually marked by a significant waste of already limited resources, innovative methods to redesign healthcare service delivery are necessary and can achieve significant cost savings,” said Richard D. Urman, MD, MBA, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USA. “Our systematic review suggests that time-driven activity-based costing can be an effective technique to support value-based initiatives when it is defined as the objective of studies that use this method. This review allowed us to conclude that the highest contributions to value-based initiatives achieved using time-driven activity-based costing are the episode of care-cycle optimization throughout the care trajectory and the identification of care benchmarks.”

Successful implementation of value-based healthcare requires an assessment of real healthcare costs by using methods that allow the evaluation of how each patient consumes resources in the healthcare system. The cost assessment method, which is termed time-driven activity-based costing, allows more detailed direct and indirect cost accounting and data accuracy by identifying patient-specific resource consumption over the course of the care trajectory. As such, the findings of this systematic review suggest that the time-driven activity-based costing methodology could become the gold standard to achieve better cost accuracy, understand healthcare resource allocation, reduce waste, and improve transparency in real-world settings. Additional information about improving the quality of studies that apply time-driven activity-based costing methodology to healthcare, can be found at the Healthcare Consortium.

###

 

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2018 impact factor score is 5.037. Value in Health is ranked 5th of 98 journals in healthcare sciences and services, 4th of 81 journals in health policy and services, and 11th of 363 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website  | Twitter (@isporjournals)

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×